{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:26:30Z","timestamp":1791260790486,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Youth Science Foundation of the Cancer Hospital of Shantou University Medical College","award":["Grant No. 2023A002"],"award-info":[{"award-number":["Grant No. 2023A002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02225-8","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:13:35Z","timestamp":1769498015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["HSP90AA1\u2013VDAC1 interaction contributes to breast cancer progression and doxorubicin resistance through PI3K\/AKT signaling"],"prefix":"10.1186","volume":"28","author":[{"given":"Yutong","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengtao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jundong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"3","key":"2225_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2225_CR2","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2225_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11864-012-0184-6","volume":"13","author":"C Marquette","year":"2012","unstructured":"Marquette C, Nabell L. Chemotherapy-resistant metastatic breast cancer. Curr Treat Options Oncol. 2012;13(2):263\u201375.","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"2225_CR4","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1038\/s41467-018-04820-6","volume":"9","author":"H Sparks","year":"2018","unstructured":"Sparks H, Kondo H, Hooper S, et al. Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy. Nat Commun. 2018;9(1):2662.","journal-title":"Nat Commun"},{"issue":"4","key":"2225_CR5","first-page":"287","volume":"35","author":"AA Kovalev","year":"2013","unstructured":"Kovalev AA, Tsvetaeva DA, Grudinskaja TV. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer. Exp Oncol. 2013;35(4):287\u201390.","journal-title":"Exp Oncol"},{"issue":"7579","key":"2225_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature15748","volume":"527","author":"KR Fischer","year":"2015","unstructured":"Fischer KR, Durrans A, Lee S, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527(7579):472\u20136.","journal-title":"Nature"},{"issue":"9","key":"2225_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jnci\/djp067","volume":"101","author":"FP O'Malley","year":"2009","unstructured":"O\u2019Malley FP, Chia S, Tu D, et al. Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. J Natl Cancer Inst. 2009;101(9):644\u201350.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2225_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.7150\/ijbs.6.773","volume":"6","author":"X Ling","year":"2010","unstructured":"Ling X, Zhou Y, Li SW, Yan B, Wen L. Modulation of mitochondrial permeability transition pore affects multidrug resistance in human hepatocellular carcinoma cells. Int J Biol Sci. 2010;6(7):773\u201383.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"2225_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2020.129556","volume":"1864","author":"DE Durrant","year":"2020","unstructured":"Durrant DE, Das A, Dyer S, Kukreja RC. A dual PI3 kinase\/mTOR inhibitor BEZ235 reverses doxorubicin resistance in ABCB1 overexpressing ovarian and pancreatic cancer cell lines. Biochim Biophys Acta Gen Subj. 2020;1864(6):129556.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"5","key":"2225_CR10","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1007\/s11033-019-04958-6","volume":"46","author":"M Panda","year":"2019","unstructured":"Panda M, Biswal BK. Cell signaling and cancer: a mechanistic insight into drug resistance. Mol Biol Rep. 2019;46(5):5645\u201359.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2225_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010173","volume":"22","author":"D Miricescu","year":"2020","unstructured":"Miricescu D, Totan A, Stanescu-Spinu II, Badoiu SC, Stefani C, Greabu M. PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects. Int J Mol Sci. 2020;22(1):173.","journal-title":"Int J Mol Sci"},{"issue":"1738","key":"2225_CR12","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0524","volume":"373","author":"SK Calderwood","year":"2018","unstructured":"Calderwood SK. Heat shock proteins and cancer: intracellular chaperones or extracellular signalling ligands? Philos Trans R Soc Lond B Biol Sci. 2018;373(1738):20160524.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"8","key":"2225_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.onc.1210716","volume":"27","author":"M Ammirante","year":"2008","unstructured":"Ammirante M, Rosati A, Gentilella A, et al. The activity of hsp90 alpha promoter is regulated by NF-kappa B transcription factors. Oncogene. 2008;27(8):1175\u20138.","journal-title":"Oncogene"},{"issue":"6","key":"2225_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060532","volume":"8","author":"V Condelli","year":"2019","unstructured":"Condelli V, Crispo F, Pietrafesa M, et al. HSP90 molecular chaperones, metabolic rewiring, and epigenetics: impact on tumor progression and perspective for anticancer therapy. Cells. 2019;8(6):532.","journal-title":"Cells"},{"key":"2225_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.639596","volume":"9","author":"H Liu","year":"2021","unstructured":"Liu H, Zhang Z, Huang Y, et al. Plasma HSP90AA1 predicts the risk of breast cancer onset and distant metastasis. Front Cell Dev Biol. 2021;9:639596.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2225_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0880-6","volume":"37","author":"X Xiao","year":"2018","unstructured":"Xiao X, Wang W, Li Y, et al. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J Exp Clin Cancer Res. 2018;37(1):201.","journal-title":"J Exp Clin Cancer Res"},{"key":"2225_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100935","volume":"44","author":"J Zhang","year":"2023","unstructured":"Zhang J, Liu L, Li Y, et al. HSP90 c-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in hepatocellular carcinoma. Neoplasia. 2023;44:100935.","journal-title":"Neoplasia"},{"key":"2225_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fonc.2017.00060","volume":"7","author":"V Shoshan-Barmatz","year":"2017","unstructured":"Shoshan-Barmatz V, De S, Meir A. The mitochondrial voltage-dependent anion channel 1, Ca2+ transport, apoptosis, and their regulation. Front Oncol. 2017;7:60.","journal-title":"Front Oncol"},{"issue":"11","key":"2225_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111485","volume":"10","author":"V Shoshan-Barmatz","year":"2020","unstructured":"Shoshan-Barmatz V, Shteinfer-Kuzmine A, Verma A. VDAC1 at the intersection of cell metabolism, apoptosis, and diseases. Biomolecules. 2020;10(11):1485.","journal-title":"Biomolecules"},{"issue":"1","key":"2225_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-022-02667-2","volume":"20","author":"Y Fang","year":"2022","unstructured":"Fang Y, Liu J, Zhang Q, et al. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates. World J Surg Oncol. 2022;20(1):211.","journal-title":"World J Surg Oncol"},{"issue":"5","key":"2225_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2025.104115","volume":"105","author":"AJM Corachea","year":"2025","unstructured":"Corachea AJM, Ferrer RJE, Ty LPB, et al. Lymphovascular invasion is associated with doxorubicin resistance in breast cancer. Lab Invest. 2025;105(5):104115.","journal-title":"Lab Invest"},{"key":"2225_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41401-025-01653-0","volume":"47","author":"YP Jin","year":"2025","unstructured":"Jin YP, Xu BJ, Zhang XF, et al. Long non-coding RNA STMN1P2 promotes breast cancer doxorubicin resistance by inhibiting pyroptosis through the hnRNPU-EZH2-TARF6-MALT1-caspase-1 pathway. Acta Pharmacol Sin. 2025;47:419\u201333.","journal-title":"Acta Pharmacol Sin"},{"issue":"24","key":"2225_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16244273","volume":"16","author":"R Vishnubalaji","year":"2024","unstructured":"Vishnubalaji R, Alajez NM. Disrupted lipid metabolism, cytokine signaling, and dormancy: hallmarks of doxorubicin-resistant triple-negative breast cancer models. Cancers (Basel). 2024;16(24):4273.","journal-title":"Cancers (Basel)"},{"issue":"18","key":"2225_CR24","doi-asserted-by":"publisher","first-page":"15968","DOI":"10.1021\/acs.jmedchem.4c00966","volume":"67","author":"X Liang","year":"2024","unstructured":"Liang X, Chen R, Wang C, Wang Y, Zhang J. Targeting HSP90 for cancer therapy: current progress and emerging prospects. J Med Chem. 2024;67(18):15968\u201395.","journal-title":"J Med Chem"},{"issue":"1","key":"2225_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12672-024-01021-0","volume":"15","author":"B Liu","year":"2024","unstructured":"Liu B, Qian D. Hsp90\u03b1 and cell death in cancers: a review. Discov Oncol. 2024;15(1):151.","journal-title":"Discov Oncol"},{"issue":"2","key":"2225_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.bbamem.2018.11.009","volume":"1861","author":"P Li","year":"2019","unstructured":"Li P, Wang J, Zou Y, et al. Interaction of Hsp90AA1 with phospholipids stabilizes membranes under stress conditions. Biochim Biophys Acta Biomembr. 2019;1861(2):457\u201365.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"3","key":"2225_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/15548627.2015.1017184","volume":"11","author":"B Hu","year":"2015","unstructured":"Hu B, Zhang Y, Jia L, et al. Binding of the pathogen receptor HSP90AA1 to avibirnavirus VP2 induces autophagy by inactivating the AKT-MTOR pathway. Autophagy. 2015;11(3):503\u201315.","journal-title":"Autophagy"},{"issue":"15","key":"2225_CR28","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1038\/s41388-020-1212-9","volume":"39","author":"M Bessou","year":"2020","unstructured":"Bessou M, Lopez J, Gadet R, et al. The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production. Oncogene. 2020;39(15):3056\u201374.","journal-title":"Oncogene"},{"issue":"12","key":"2225_CR29","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.7150\/jca.71592","volume":"13","author":"L Xue","year":"2022","unstructured":"Xue L, Wu M, Li Y, et al. Hexokinase 2 is a pivot for lovastatin-induced glycolysis-to-autophagy reprogramming in triple-negative breast cancer cells. J Cancer. 2022;13(12):3368\u201377.","journal-title":"J Cancer"},{"issue":"1","key":"2225_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","volume":"570","author":"AD Zuehlke","year":"2015","unstructured":"Zuehlke AD, Beebe K, Neckers L, Prince T. Regulation and function of the human HSP90AA1 gene. Gene. 2015;570(1):8\u201316.","journal-title":"Gene"},{"issue":"6","key":"2225_CR31","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1074\/jbc.REV118.002806","volume":"294","author":"O Genest","year":"2019","unstructured":"Genest O, Wickner S, Doyle SM. Hsp90 and Hsp70 chaperones: collaborators in protein remodeling. J Biol Chem. 2019;294(6):2109\u201320.","journal-title":"J Biol Chem"},{"issue":"5","key":"2225_CR32","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2174\/092986712798992110","volume":"19","author":"V Shoshan-Barmatz","year":"2012","unstructured":"Shoshan-Barmatz V, Golan M. Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy. Curr Med Chem. 2012;19(5):714\u201335.","journal-title":"Curr Med Chem"},{"issue":"12","key":"2225_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/cancers10120499","volume":"10","author":"T Arif","year":"2018","unstructured":"Arif T, Paul A, Krelin Y, Shteinfer-Kuzmine A, Shoshan-Barmatz V. Mitochondrial VDAC1 silencing leads to metabolic rewiring and the reprogramming of tumour cells into advanced differentiated states. Cancers (Basel). 2018;10(12):499.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"2225_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112850","volume":"13","author":"E Zerbib","year":"2021","unstructured":"Zerbib E, Arif T, Shteinfer-Kuzmine A, Chalifa-Caspi V, Shoshan-Barmatz V. VDAC1 silencing in cancer cells leads to metabolic reprogramming that modulates tumor microenvironment. Cancers (Basel). 2021;13(11):2850.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2225_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12041031","volume":"12","author":"Z Amsalem","year":"2020","unstructured":"Amsalem Z, Arif T, Shteinfer-Kuzmine A, Chalifa-Caspi V, Shoshan-Barmatz V. The mitochondrial protein VDAC1 at the crossroads of cancer cell metabolism: the epigenetic link. Cancers (Basel). 2020;12(4):1031.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2225_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.15698\/cst2017.10.104","volume":"1","author":"V Shoshan-Barmatz","year":"2017","unstructured":"Shoshan-Barmatz V, Maldonado EN, Krelin Y. VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress. Cell Stress. 2017;1(1):11\u201336.","journal-title":"Cell Stress"},{"issue":"9","key":"2225_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biom14091139","volume":"14","author":"A Shteinfer-Kuzmine","year":"2024","unstructured":"Shteinfer-Kuzmine A, Santhanam M, Shoshan-Barmatz V. VDAC1-based peptides as potential modulators of VDAC1 interactions with its partners and as a therapeutic for cancer, NASH, and diabetes. Biomolecules. 2024;14(9):1139.","journal-title":"Biomolecules"},{"key":"2225_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-017-3250-3","author":"A Wagatsuma","year":"2018","unstructured":"Wagatsuma A, Takayama Y, Hoshino T, et al. Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway. Mol Cell Biochem. 2018. https:\/\/doi.org\/10.1007\/s11010-017-3250-3.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"2225_CR39","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3892\/or.2017.5797","volume":"38","author":"JH Qin","year":"2017","unstructured":"Qin JH, Wang K, Fu XL, et al. Hsp90 inhibitor induces KG-1a cell differentiation and apoptosis via Akt\/NF-\u03baB signaling. Oncol Rep. 2017;38(3):1517\u201324.","journal-title":"Oncol Rep"},{"issue":"11","key":"2225_CR40","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/biom10111485","volume":"10","author":"V Shoshan-Barmatz","year":"2020","unstructured":"Shoshan-Barmatz V, Shteinfer-Kuzmine A, Verma A. VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases. Biomolecules. 2020;10(11):1485.","journal-title":"Biomolecules"},{"key":"2225_CR41","doi-asserted-by":"crossref","unstructured":"Liu H, Liang S, Peng C, Yang J, Yang Z, Mo W. NSUN3-Mediated ROS Accumulation Promotes Hepatocellular Carcinoma Proliferation and Activates PI3K\/AKT Pathway. Biochem Genet. Published online June 23, 2025.","DOI":"10.1007\/s10528-025-11158-4"},{"issue":"1","key":"2225_CR42","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1038\/s41598-025-87389-7","volume":"15","author":"X Wu","year":"2025","unstructured":"Wu X, Li Y, Wang W, et al. DRAM1 enhances the proliferation and metastasis of gastric cancer through the PI3K\/AKT\/mTOR signaling pathway and energy metabolism. Sci Rep. 2025;15(1):3542.","journal-title":"Sci Rep"},{"issue":"3","key":"2225_CR43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/2211-5463.13940","volume":"15","author":"L Chen","year":"2025","unstructured":"Chen L, Chen M, Xie Y, et al. 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione mediates the effect of ROS-enhanced PI3K\/Akt\/mTOR pathway on autophagy in breast cancer. FEBS Open Bio. 2025;15(3):474\u201389.","journal-title":"FEBS Open Bio"},{"issue":"5","key":"2225_CR44","doi-asserted-by":"publisher","first-page":"101410","DOI":"10.1016\/j.jceh.2024.101410","volume":"14","author":"SS Saluja","year":"2024","unstructured":"Saluja SS, Sharma AK, et al. Impact of ABCB1 and ABCG2 transporter in outcome of gallbladder cancer. J Clin Exp Hepatol. 2024;14(5):101410.","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"2225_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071056","volume":"12","author":"CP Wu","year":"2023","unstructured":"Wu CP, Hung CY, Hsieh YJ, et al. ABCB1 and ABCG2 overexpression mediates resistance to the phosphatidylinositol 3-kinase inhibitor HS-173 in cancer cell lines. Cells. 2023;12(7):1056.","journal-title":"Cells"},{"issue":"4","key":"2225_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10637-017-0556-7","volume":"36","author":"A Canonici","year":"2018","unstructured":"Canonici A, Qadir Z, Conlon NT, et al. The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells. Invest New Drugs. 2018;36(4):581\u20139.","journal-title":"Invest New Drugs"},{"key":"2225_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2018.07.012","volume":"434","author":"X Chen","year":"2018","unstructured":"Chen X, Liu P, Wang Q, et al. DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction. Cancer Lett. 2018;434:70\u201380.","journal-title":"Cancer Lett"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02225-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02225-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02225-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:03:59Z","timestamp":1770897839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02225-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2225"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02225-8","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of human specimens and animal experiments in this study was reviewed and approved by the Ethics Committee of the Cancer Hospital of Shantou University Medical College, China (Approval No. 2023120). Written informed consent was obtained from all participants prior to the collection and use of their clinical specimens, in accordance with the principles of the Declaration of Helsinki. All animal experiments were conducted in compliance with institutional guidelines, relevant national regulations, and internationally accepted principles for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}